Abstract/Details

Protein kinase A and the forced swim test: A strain comparison


2006 2006

Other formats: Order a copy

Abstract (summary)

The second messenger cyclic AMP (cAMP) has been long documented as affected by antidepressant (AD) treatment. AD drugs typically take days to weeks to produce clinical efficacy. Although cAMP levels may be elevated by short-term AD administration, chronic AD's may be necessary to affect all of the components of the cAMP cascade, including the second messenger's receptor, protein kinase A (PKA). The first report to examine PKA binding in the human depressive brain was not published until 1997 (Lowther, Katona, Crompton, & Horton). PKA density was unaltered as demonstrated via saturation binding in five brain regions in depressive suicides, yet decreased in those currently taking AD drugs. No published account regarding a controlled study of the impact of chronic AD treatment on PKA density exists. Strain differences may exist for AD effects on biochemistry, as well as behavior. Two strains, one "normal" (Sprague-Dawley, SD) and one exhibiting depressive characteristics (Wistar Kyoto, WKY) were tested for changes in both measures as a result of subchronic and chronic AD treatment. These two strains were known previously to differ in their responses to the forced swim test (FST), an animal model of depression that detects AD activity with a high correlation to clinical efficacy. Firstly, the pharmacological profile of a single PKA receptor in two fractions, the cytosolic and particulate, of the frontal cortex was determined. Secondly, strain differences in PKA density and FST response to the clinically utilized AD's desipramine and bupropion were assessed. Alprazolam did not demonstrate an AD-like effect in the FST. The two rat strains differed in their control levels of FST behavior and PKA density, but not affinities. Only the SD strain showed PKA density changes at a low AD dose and only in the particulate fraction. The PKA density changes in both strains in the cytosolic fraction occurred only at the high dose of an AD, perhaps reflecting transcriptional processes. No consistent correlation between biochemistry and behavior was found. Both how the FST measures AD activity with clinical drug effect concordance and if AD effect can be fingerprinted via changes in PKA density remain unsolved.

Indexing (details)


Subject
Psychobiology;
Proteins;
Swimming;
Comparative analysis;
Tests;
Strain
Classification
0349: Psychobiology
Identifier / keyword
Psychology; Antidepressant; Depression; Forced swim test; Protein kinase A; Strain comparison
Title
Protein kinase A and the forced swim test: A strain comparison
Author
Rogacki, Nancy
Number of pages
144
Publication year
2006
Degree date
2006
School code
0046
Source
DAI-B 67/01, Dissertation Abstracts International
Place of publication
Ann Arbor
Country of publication
United States
ISBN
9780542510687, 0542510685
Advisor
Barr, Gordon A.
University/institution
City University of New York
University location
United States -- New York
Degree
Ph.D.
Source type
Dissertations & Theses
Language
English
Document type
Dissertation/Thesis
Dissertation/thesis number
3205018
ProQuest document ID
305356440
Copyright
Database copyright ProQuest LLC; ProQuest does not claim copyright in the individual underlying works.
Document URL
http://search.proquest.com/docview/305356440
Access the complete full text

You can get the full text of this document if it is part of your institution's ProQuest subscription.

Try one of the following:

  • Connect to ProQuest through your library network and search for the document from there.
  • Request the document from your library.
  • Go to the ProQuest login page and enter a ProQuest or My Research username / password.